Study of MK-7162 in Combination With Pembrolizumab (MK-3475) in Adult Participants With Advanced Solid Tumors (MK-7162-002)
Clinical trial NCT03364049 · COMPLETED
Trial details
- NCT number
- NCT03364049
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-06
- Primary completion
- 2020-10-19
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.